Addressing a Critical Need for the Global Lupus Community

By Susan M. Manzi, MD, Kenneth A. Getz

Global experts collaborate to form the Addressing Lupus Pillars for Health Advancement (ALPHA) Project in order to combat challenges in lupus drug development.

Using AI & Machine Learning to Better Understand Data and Manage Risk

By Basheer Hawwash

Basheer Hawwash, Principal Data Scientist at Remarque Systems Inc., writes of the potential artificial intelligence, more specifically machine learning, has to transform clinical trials.

eClinical Technology Considerations for Cell and Gene Therapy Studies: Case Study Snapshots of Personalized Medicine

By Dan Pavitt, Kevin Pounds

With the world of gene therapy still rapidly evolving, an Interactive Response Technology system might help a sponsor navigate new and complex steps throughout the supply chain.


New Models to Raise Public and Patient Awareness

Tracking the evolution and effectiveness of CISCRP’s clinical research awareness and literacy campaigns.

Sharing Stories of Clinical Trial Participation from Start to Finish

How mapping patients’ health journeys can drive a deeper understanding of their experiences and motivations.

Patient Experiences with Clinical Trial Medicines and Instructions

Providing easy to understand and culturally appropriate investigational medication education and support can make all the difference in improving the patient experience.



3rd Annual Medical Writers Summit

September 25 - 26, 2019
Philadelphia, PA

4th Annual Lay Summaries Summit

September 25 - 26, 2019
Philadelphia, PA

16th Annual Patient Summit USA

October 02 - 03, 2019
Sheraton Philadelphia Society Hill Hotel, Philadelphia, PA


Alzheimer’s Disease Research Finds New Beginnings

By Moe Alsumidaie

Dr. Daniel Alkon, President & Chief Science Officer at Neurotrope, discusses novel approaches to AD therapy development and why his company chose to target patients with advanced AD for their own.

Big CROs Dive into Offering AI/ML Solutions

By Moe Alsumidaie

Benjamin Hughes, SVP of AI and Real-World Data at IQVIA, discusses how AI is changing the clinical trial paradigm, and how the technologies IQVIA is developing are different from other tech companies that specialize in AI/ML

Overcoming The Hurdles of Starting up a Biopharmaceutical Company

By Moe Alsumidaie

CEO of eXIthera, Neil Hayward, talks about his experience overcoming the challenges of starting up an emerging biopharmaceutical company, including the challenges of preclinical and early-stage development.

Peer-Reviewed Articles

Biases in Characterization of Oncology Trials for Policy Decisions

By Chris Barker

Chris Barker, an Independent Statistical Consultant, discusses the differences and biases in summaries obtained from a database called PDQ vs. CTG.

The Well-Adjusted Statistician: Analysis of Covariance Explained

By Stephen Senn, PhD

How to account and adjust for covariates in clinical trial randomization—and be confident about uncertainty.

Portfolio Approach to Optimize Site Selection

By Vadim Paluy, MD, Vladimir Shnaydman, PhD

Site selection is one of the most important and at the same time challenging problems in clinical trials planning. Poor site selection may cause enrollment delays, resource waste on low or zero enrollment, and even potentially compromise trial results.


Outcomes in Focus: Best Practices for eCOA

This eBook on Outcomes in Focus: Best Practices for eCOA covers considerations and practical advice for smooth eCOA implementation; secrets to eCOA success from industry insiders; and new opportunities for the use of eCOA in clinical trials.

View all eBooks


lorem ipsum